Development of a Bionic Voice Device
Project description and overview:
Laronix’s first patented product, Bionic Voice, is a world’s first and only smart natural-sounding artificial voice-box for people suffering from permanent voice-loss.
Bionic Voice is a smart non-invasive artificial larynx, which generates a natural-sounding voice for people without a functional larynx. Laronix has built an MVP and performed successful clinical trials with multiple patients.
Bionic Voice is an electronic device placed outside the body. It monitors patient’s respiration using sensors outside the neck. Inside the device, there is a software module that mimics the performance of human vocal cords and generates a natural sounding voice automatically in response to respiration. The generated voice is transferred to the mouth via a thin tube. The patient uses this voice and speaks with it. This voice is modified into speech when the patient moves their face and lip muscles.
Laronix’s Bionic Voice is an FDA/TGA registered Class 1 device to facilitate access to Australian and US markets. The Bionic Voice unit is completely non-invasive, thereby eliminating all of the biohazards of conventional solutions.
- Increased spending on R&D
- Increased collaboration with other manufacturers
- Increased number of staff with science, technology, engineering, and maths (STEM) skills
- Better qualified employees
- Larger patent portfolio
- Laronix forecast $73M in revenue over 5 years
- This project is projected to upskill and create an additional 16 jobs
Government Funds: $408,768 | Industry: $408,768